Kuehn Law, PLLC News Releases

Kuehn Law Encourages Investors of Kyndryl Holdings, Inc. to Contact Law Firm

Tue, 16 Jun 2026 21:56:00 -0400

New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Kyndryl Holdings, Inc. (NYSE: KD) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Kyndryl Holdings misrepresented or failed to disclose that: (1) certain members of executive management engaged in systematic manipulation of the Company's free cash flow metrics through the deliberate...

Kuehn Law Encourages Investors of Franklin BSP Realty Trust, Inc. to Contact Law Firm

Tue, 16 Jun 2026 21:50:00 -0400

New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Franklin BSP Realty Trust misrepresented or failed to disclose that the Company had recklessly overstated: (1) its earnings prospects; and (2) its ability to maintain a $0.355 dividend per share...

Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm

Tue, 16 Jun 2026 21:43:00 -0400

New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Corcept Therapeutics Incorporated (NASDAQ: CORT) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Corcept Therapeutics Incorporated failed to disclose adverse facts concerning potential FDA approval of one of the Company's lead new product candidates, relacorilant, a medication being...

Kuehn Law Encourages Investors of BlackRock TCP Capital Corp to Contact Law Firm

Wed, 03 Jun 2026 11:05:00 -0400

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of BlackRock TCP Capital Corp (NASDAQ: TCPC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at BlackRock TCP Capital caused the company to misrepresent or fail to disclose that (1) the Company's investments were not being timely and/or appropriately valued; (2) the Company's efforts...

Kuehn Law Encourages Investors of Richtech Robotics Inc. to Contact Law Firm

Wed, 03 Jun 2026 11:03:00 -0400

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Richtech Robotics Inc. (NASDAQ: RR) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Richtech Robotics caused the company to misrepresent or fail to disclose that (1) Richtech claimed that it had a collaborative and commercial relationship with Microsoft when it did not; and (2)...

Kuehn Law Encourages Investors of Picard Medical Inc. to Contact Law Firm

Wed, 03 Jun 2026 11:02:00 -0400

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Picard Medical Inc. (NYSE American: PMI) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Picard Medical caused the company to misrepresent or fail to disclose that (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and...

Kuehn Law Encourages Investors of Plug Power Inc. to Contact Law Firm

Wed, 03 Jun 2026 11:00:00 -0400

New York, New York--(Newsfile Corp. - June 3, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Plug Power Inc. (NASDAQ: PLUG) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Plug Power caused the company to misrepresent or fail to disclose that: (i) the likelihood that funds attributed to the DOE Loan would ultimately become available to Plug Power was materially...

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm

Mon, 01 Jun 2026 17:50:00 -0400

New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Ultragenyx Pharmaceutical caused the company to misrepresent or fail to disclose the true state of setrusumab's potential and the risk inherent in the study protocols put forth;...

Kuehn Law Encourages Investors of Oracle Corporation to Contact Law Firm

Mon, 01 Jun 2026 17:37:00 -0400

New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Oracle Corporation (NYSE: ORCL) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Oracle caused the company to misrepresent or fail to disclose that: (1) the Company's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in...

Kuehn Law Encourages Investors of Inovio Pharmaceuticals, Inc. to Contact Law Firm

Mon, 01 Jun 2026 17:24:00 -0400

New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inovio Pharmaceuticals caused the company to misrepresent or fail to disclose that (i) manufacturing for Inovio's CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to...